Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate
Novavax’ proprietary Matrix-M vaccine adjuvant enhances immune response of malaria antigen developed at Jenner Institute at Oxford University Phase 2b clinical efficacy study of experimental malaria vaccine with Matrix‑M nearing completion in Burkina Faso GAITHERSBURG,…